Skip to main content
Liezl Gamble Photo
Liezl Gambe

Liezl Gambe

GrafaFinance Journalist

Finance journalist at Grafa with years of experience covering Asia-Pacific financial markets at S&P Global, Mortgage Ezy, and GMA Network.

Articles by Liezl Gambe

Grafa
Health

Acadia advances remlifanserin program after Phase 2 Alzheimer’s trial results

Acadia Pharmaceuticals (NASDAQ:ACAD) announced Phase 3-enabling topline results from the Phase 2 portion of its ongoing RADIANT clinical trial program evaluating remlifanserin for hallucinations and delusions associated with Alzheimer’s disease psychosis (ADP).

Read more: Acadia advances remlifanserin program after Phase 2 Alzheimer’s trial results